JP2016513537A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513537A5
JP2016513537A5 JP2016501858A JP2016501858A JP2016513537A5 JP 2016513537 A5 JP2016513537 A5 JP 2016513537A5 JP 2016501858 A JP2016501858 A JP 2016501858A JP 2016501858 A JP2016501858 A JP 2016501858A JP 2016513537 A5 JP2016513537 A5 JP 2016513537A5
Authority
JP
Japan
Prior art keywords
patent document
pat
oral
drug
holder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/025483 external-priority patent/WO2014159934A1/en
Publication of JP2016513537A publication Critical patent/JP2016513537A/ja
Publication of JP2016513537A5 publication Critical patent/JP2016513537A5/ja
Pending legal-status Critical Current

Links

JP2016501858A 2013-03-14 2014-03-13 経口剤形用の対小児安全カバー Pending JP2016513537A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361781966P 2013-03-14 2013-03-14
US61/781,966 2013-03-14
PCT/US2014/025483 WO2014159934A1 (en) 2013-03-14 2014-03-13 Child resistant cover for oral dosage forms

Publications (2)

Publication Number Publication Date
JP2016513537A JP2016513537A (ja) 2016-05-16
JP2016513537A5 true JP2016513537A5 (enExample) 2017-03-30

Family

ID=50442704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016501858A Pending JP2016513537A (ja) 2013-03-14 2014-03-13 経口剤形用の対小児安全カバー

Country Status (8)

Country Link
US (1) US20160001957A1 (enExample)
EP (1) EP2968072B1 (enExample)
JP (1) JP2016513537A (enExample)
CA (1) CA2903828A1 (enExample)
HK (1) HK1218617A1 (enExample)
IL (1) IL241088A0 (enExample)
MX (1) MX2015011634A (enExample)
WO (1) WO2014159934A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
CN107737400B (zh) * 2017-11-17 2020-09-01 上海中医药大学附属岳阳中西医结合医院 一种肛门药栓推进器

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2017783A (en) * 1933-10-09 1935-10-15 Joseph C Clark Capsule administering device
US2469399A (en) * 1945-04-17 1949-05-10 Ciba Pharm Prod Inc Disposable dispensing device
US4474308A (en) * 1982-09-30 1984-10-02 Michel Bergeron Tablet ejector
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5399162A (en) * 1994-02-23 1995-03-21 Cselle; Edward Automatic balling gun
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US7744558B2 (en) * 2007-06-06 2010-06-29 Maag R John Pill plunger
US7976489B2 (en) * 2007-12-04 2011-07-12 Orapharma, Inc. Device for delivering medicinal implants
US7988016B2 (en) * 2008-02-06 2011-08-02 Klein Seth A Medicine container with single pill dispenser
BRPI0911229A2 (pt) * 2008-04-09 2015-09-29 Merck Serono Sa recipiente para medicamentos resistente a crianças
WO2012155091A1 (en) * 2011-05-11 2012-11-15 Kirax Corporation Package for improved treatment of conditions

Similar Documents

Publication Publication Date Title
IL285440A (en) Oral compositions containing octreotide in combination with other therapeutic agents for tretment of acromegaly
JP2014532727A5 (enExample)
HUE046671T2 (hu) Glutárimid származékokat tartalmazó gyógyászati készítmény, valamint ennek alkalmazása eozinofil betegségek kezelésében
CY1124115T1 (el) Η χρηση τριβενζοϊκου γλυκερυλιου που περιεχει συνθεση σε νευροεκφυλιστικες διαταραχες
CY1118100T1 (el) Διαλυμα ατομοξετινης
MX385518B (es) FORMULACIÓN QUE TIENE CARACTERÍSTICAS MEJORADAS DE LIBERACIÓN DE FÁRMACOS pH DEPENDIENTES, QUE CONTIENEN ESOMEPRAZOL O UNA DE SUS SALES FARMACÉUTICAS ACEPTABLE.
JP2016513537A5 (enExample)
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
TH182343B (th) องค์ประกอบทางเภสัชกรรมที่เสถียรซึ่งต้านวัณโรคในรูปของยาเม็ดแบนชนิดที่แตกตัว อย่างรวดเร็วซึ่งประกอบรวมด้วยแกรนูลของไอโซไนอาซิดและแกรนูลของ ไรฟาเพนทีน และกระบวนการเตรียมของมัน
CN302525309S (zh) 包装袋(中药饮片)
CN302524264S (zh) 个人冲泡器(s-013)
CN302524265S (zh) 个人冲泡器(s-011)
CN302401349S (zh) 化妆瓶(yy-5097)
CN302401350S (zh) 化妆瓶(yy-5100)
CN302509001S (zh) 个人冲泡器(s-010)
CN302524263S (zh) 个人冲泡器(s-015)
CN302277106S (zh) 药品包装盒(盐酸舍曲林胶囊)
CR20190401A (es) Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas
CN302401297S (zh) 包装瓶(焕颜活肤精华洁面乳)
CN302524262S (zh) 个人冲泡器(s-014)
CN302544664S (zh) 粉盒
CN302418023S (zh) 医用剪(ph-2602)
CN302052562S (zh) 包装盒(tsl-csc)
CN302252224S (zh) 乳液瓶(素心兰滋润赋活乳液)
AR100910A1 (es) Forma de dosificación oral de liberación sostenida que contiene morfina y naloxona